Tetraphase Pharmaceuticals Inc

FDA Filings

This page includes the latest FDA filings for Tetraphase Pharmaceuticals Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

USA

NASDAQ

TTPH

DUNS 790935717

FDA Registration(s)

FDA Filings

Device Company	Device	Date
Xerava Tetraphase Pharmaceuticals, Inc.	Prescription Medication	2024-02-17
Xerava Tetraphase Pharmaceuticals, Inc.	Prescription Medication	2023-12-29
Xerava Tetraphase Pharmaceuticals, Inc.	Prescription Medication	2021-10-12
Xerava Tetraphase Pharmaceuticals, Inc.	Prescription Medication	2020-06-16
Xerava Tetraphase Pharmaceuticals, Inc.	Prescription Medication	2019-10-22
Xerava Tetraphase Pharmaceuticals, Inc.	Prescription Medication	2019-06-21
NDC 71773-100 Tetraphase Pharmaceuticals, Inc.	Xerava	2018-09-10
NDC 71773-050 Tetraphase Pharmaceuticals, Inc.	Xerava	2018-09-10

Similar & Related FDA Registered Companies

Related Finance Registrations

NCAGE Code	5E0R0	TETRAPHASE PHARMACEUTICALS, INC.!DBA TETRAPHASE PHARMACEUTICALS
CAGE Code	5E0R0	TETRAPHASE PHARMACEUTICALS, INC. TETRAPHASE PHARMACEUTICALS TETRAPHASE PHARMA
S.A.M. Registration	5E0R0 [790935717]	TETRAPHASE PHARMACEUTICALS, INC. TETRAPHASE PHARMACEUTICALS
SEC	0001373707	TETRAPHASE PHARMACEUTICALS INC of DELAWARE